167 related articles for article (PubMed ID: 8337704)
1. A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction.
Kedderis LB; Mills JJ; Andersen ME; Birnbaum LS
Toxicol Appl Pharmacol; 1993 Jul; 121(1):87-98. PubMed ID: 8337704
[TBL] [Abstract][Full Text] [Related]
2. Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat: biliary excretion and induction of cytochromes CYP1A1 and CYP1A2.
Kedderis LB; Diliberto JJ; Linko P; Goldstein JA; Birnbaum LS
Toxicol Appl Pharmacol; 1991 Oct; 111(1):163-72. PubMed ID: 1949032
[TBL] [Abstract][Full Text] [Related]
3. Effects of dose and routes of exposure on the disposition of 2,3,7,8-[3H]tetrabromodibenzo-p-dioxin (TBDD) in the rat.
Diliberto JJ; Kedderis LB; Jackson JA; Birnbaum LS
Toxicol Appl Pharmacol; 1993 Jun; 120(2):315-26. PubMed ID: 8511802
[TBL] [Abstract][Full Text] [Related]
4. Tissue distribution after a single subcutaneous administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in comparison with toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Wistar rats.
Nagao T; Yamashita K; Golor G; Bittmann H; Körner W; Hagenmaier H; Neubert D
Life Sci; 1996; 58(4):325-36. PubMed ID: 8538369
[TBL] [Abstract][Full Text] [Related]
5. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relationships for disposition and hepatic sequestration of polyhalogenated dibenzo-p-dioxins, dibenzofurans, and biphenyls following subchronic treatment in mice.
DeVito MJ; Ross DG; Dupuy AE; Ferrario J; McDaniel D; Birnbaum LS
Toxicol Sci; 1998 Dec; 46(2):223-34. PubMed ID: 10048125
[TBL] [Abstract][Full Text] [Related]
7. Disposition and excretion of intravenous 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in rats.
Kedderis LB; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 1991 May; 108(3):397-406. PubMed ID: 2020967
[TBL] [Abstract][Full Text] [Related]
8. A physiological pharmacokinetic description of the tissue distribution and enzyme-inducing properties of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat.
Leung HW; Paustenbach DJ; Murray FJ; Andersen ME
Toxicol Appl Pharmacol; 1990 May; 103(3):399-410. PubMed ID: 2160135
[TBL] [Abstract][Full Text] [Related]
9. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
[TBL] [Abstract][Full Text] [Related]
10. Estimated cancer risk of dioxins to humans using a bioassay and physiologically based pharmacokinetic model.
Maruyama W; Aoki Y
Toxicol Appl Pharmacol; 2006 Jul; 214(2):188-98. PubMed ID: 16443251
[TBL] [Abstract][Full Text] [Related]
11. Toxicokinetics.
van Birgelen AP; van den Berg M
Food Addit Contam; 2000 Apr; 17(4):267-73. PubMed ID: 10912241
[TBL] [Abstract][Full Text] [Related]
12. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
[TBL] [Abstract][Full Text] [Related]
13. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation.
Andersen ME; Birnbaum LS; Barton HA; Eklund CR
Toxicol Appl Pharmacol; 1997 May; 144(1):145-55. PubMed ID: 9169078
[TBL] [Abstract][Full Text] [Related]
14. Determination of parameters responsible for pharmacokinetic behavior of TCDD in female Sprague-Dawley rats.
Wang X; Santostefano MJ; Evans MV; Richardson VM; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 1997 Nov; 147(1):151-68. PubMed ID: 9356318
[TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunotoxicity among tetrachloro-, pentachloro-, tetrabromo- and pentabromo-dibenzo-p-dioxins in mice.
Ao K; Suzuki T; Murai H; Matsumoto M; Nagai H; Miyamoto Y; Tohyama C; Nohara K
Toxicology; 2009 Feb; 256(1-2):25-31. PubMed ID: 19041680
[TBL] [Abstract][Full Text] [Related]
17. Dose- and time-dependent effects of 2,3,7,8-tetrabromodibenzo-p-dioxin on rat liver.
Ohbayashi H; Sasaki T; Matsumoto M; Noguchi T; Yamazaki K; Aiso S; Nagano K; Arito H; Yamamoto S
J Toxicol Sci; 2007 Feb; 32(1):47-56. PubMed ID: 17327693
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity analysis of a physiological model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): assessing the impact of specific model parameters on sequestration in liver and fat in the rat.
Evans MV; Andersen ME
Toxicol Sci; 2000 Mar; 54(1):71-80. PubMed ID: 10746933
[TBL] [Abstract][Full Text] [Related]
19. Chemical characterization and disposition studies with 1,2,7,8-tetrabromodibenzofuran in the rat.
Kedderis LB; Jackson JA; Patterson DG; Grainger J; Diliberto JJ; Birnbaum LS
J Toxicol Environ Health; 1994 Jan; 41(1):53-69. PubMed ID: 8277526
[TBL] [Abstract][Full Text] [Related]
20. Use of tissue disposition data from rats and dogs to determine species differences in input parameters for a physiological model for perchloroethylene.
Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
Environ Res; 1994 Oct; 67(1):54-67. PubMed ID: 7925194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
